ARCHIVES

Immunotherapy Demonstrates Disease Control in Phase II Study

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Board Approves Three Concepts

December 19, 2014

In Brief: Former Oklahoma Re. Synar, Opponent of Tobacco, dead at 45 Of Brain Cancer

January 12, 1996

In Brief: GM awards Shared By Six Scientists; Pollard Named President of Salk Institute

June 21, 1996

Ibrutinib Demonstrates 71% ORR In Phase Ib/II CLL and SLL Study

July 26, 2013

List of FY97 SPORE Grantees and Their Awards

December 12, 1997

House and Senate Appropriators Pledge to Increase Biomedical Research Funding.

March 5, 1999